In addition to BRCA1 and BRCA2 mutations, it is crucial to recognize that various other genetic mutations, such as those in RAD51C, ATM, and CHEK2, can induce HR deficiency in ovarian cancer. The gene discussed is BRCA2; the disease is ovarian cancer.